Chanoch Miodownik, MD

Original Research

The Retinoid X Receptor Agonist Bexarotene Relieves Positive Symptoms of Schizophrenia: A 6-Week, Randomized, Double-Blind, Placebo-Controlled Multicenter Trial

December 15, 2013

Original Research

L-Theanine Relieves Positive, Activation, and Anxiety Symptoms in Patients With Schizophrenia and Schizoaffective Disorder: An 8-Week, Randomized, Double-Blind, Placebo-Controlled, 2-Center Study

November 30, 2010

Original Research

Vitamin B6 Treatment for Tardive Dyskinesia: A Randomized, Double-Blind, Placebo-Controlled, Crossover Study

November 15, 2007

Original Research

Efficacy of Piracetam in the Treatment of Tardive Dyskinesia in Schizophrenic Patients: A Randomized, Double-Blind, Placebo-Controlled Crossover Study

July 16, 2007

Original Research

The Effect of Sudden Clozapine Discontinuation on Management of Schizophrenic Patients: A Retrospective Controlled Study.

August 15, 2006

Original Research

High Serum Homocysteine Levels in Young Male Schizophrenic and Schizoaffective Patients With Tardive Parkinsonism and/or Tardive Dyskinesia

December 15, 2005

Original Research

Vitamin B6 Treatment in Acute Neuroleptic-Induced Akathisia: A Randomized, Double-Blind, Placebo-Controlled Study

November 1, 2004

Original Research

Vitamin B6 as Add-On Treatment in Chronic Schizophrenic and Schizoaffective Patients: A Double-Blind, Placebo-Controlled Study

January 1, 2002